CD274 and prostate cancer: [180] used a SC membrane (SCM) to wrap the NPs containing DOX and programmed cell death ligand 1 (PD-L1) siRNA (PDA-DOX/siPD-L1@SCM) to achieve the combine treatment of gene- and chemotherapy in a prostate cancer bone metastasis model (Fig. 13A).